CECC specialist cautions on use of Remdesivir for COVID treatment

A specialist with the Central Epidemic Command Center (CECC) on Tuesday urged caution over the use of Remdesivir to treat COVID-19 patients, saying that steroids and antibody drugs are better at treating the disease.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)